Apex Health Names Ruth Krystopolski as Executive Vice President and Chief Operating Officer

October 27, 2025 9:00 AM

Apex Health, a tech-enabled management services organization (MSO) that enhances the enterprise value of health systems, today announced the appointment of Ruth Krystopolski, MBA, as Executive Vice President and Chief Operating Officer. In this new role, Krystopolski will oversee enterprise operations and execution across Apex's growing health system partnerships.Krystopolski brings more than 30 years of executive leadership experience across...

Read more

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

October 27, 2025 8:45 AM

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Monday, October 27th, at 03:00pm at the PODD 2025 Conference in Boston, MA.Event Information:EventNanoViricides Presentation at the PODD 2025, Boston, MATrack5ADateMonday, October 27, 2025Time03:00 pmLocationSt. George, ABC, at Westin...

Read more

Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

October 27, 2025 8:30 AM

"STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic joint venture, creating Stemtech HealthSciences India Pvt Ltd, a subsidiary of Stemtech Corporation, a Nevada company (OTCQB:STEK).The India MarketStemtech Corporation Chairman & CEO, Charles S. Arnold, states "STEMTECH HEALTHSCIENCES INDIA PVT LTD (SHIPL) is dedicated to bringing...

Read more

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

October 27, 2025 7:35 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced new data from two studies of icotrokinra, a first-in-class investigational targeted oral peptide that precisely blocks the IL-23 receptor, presented at two recent medical conferences.Week 28 data from the Phase 2b ANTHEM-UC study of icotrokinra will be presented at the 2025 American College of Gastroenterology Annual Scientific Meeting (ACG), demonstrating sustained...

Read more

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

October 27, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2025 ended September 30, 2025, after the market closes on Thursday, November 6, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can...

Read more

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

October 27, 2025 2:50 AM

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that the Company has received a payment of US$ 25 m from Bristol Myers Squibb (NYSE: BMY) for scientific progress achieved within their strategic neuroscience partnership. The payment will advance further research and the partners' joint pipeline of programs aimed at tackling neurogenerative diseases.Launched in...

Read more

EXPOSÉ: DEA's Marijuana Licensing Scheme Exposed - MMJ BioPharma's Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine

October 26, 2025 2:12 PM

A recently disclosed memorandum of understanding between the DEA and a registered marijuana cultivator has revealed the DEA fatal flaw at the heart of America's cannabis research policy - one that proves MMJ BioPharma Cultivation's case and exposes why legitimate science has been paralyzed for nearly a decade.The Bureaucratic Catch-22 Under the terms of the DEA's own memorandum, licensees are required to perform highly restricted tasks:...

Read more

ASCP Foundation Unveils "The Spirits of Medication Management" - a Legacy Gift to Improve Lives Through Pharmacy

October 25, 2025 11:00 AM

The ASCP Foundation proudly announces The Spirits of Medication Management, an endowed initiative made possible through a generous contribution dedicated to improving the lives of all patients through pharmacist-driven medication management, public awareness, leadership, and systems change. This lasting gift supports efforts to reduce polypharmacy, advance safe medication use, and celebrate the expertise and compassion at the heart of...

Read more

GLPro Review (Urgent Report) Blood Sugar Support Gains Attention as Experts Raise Alarms Over Metabolic Wellness

October 25, 2025 7:40 AM

Metabolic health is undergoing a revolution. For decades, blood sugar support meant single-ingredient fixes or generic advice. But in 2025, the focus has shifted to the gut-metabolic axis, where microbial diversity, gut barrier strength, and inflammation directly influence how the body manages glucose, appetite, and energy. This is where GLPro has emerged as the First Natural Blood Sugar Formula Doctors And Insiders Are Talking About (Verified)....

Read more

GLPro Reviews (ALERT) Doctor Reveals the Truth About This #1 Blood Sugar Formula and Surprising GLPro Side Effects

October 24, 2025 6:25 PM

Metabolic health is undergoing a revolution. For decades, blood sugar support meant single-ingredient fixes or generic advice. But in 2025, the focus has shifted to the gut-metabolic axis, where microbial diversity, gut barrier strength, and inflammation directly influence how the body manages glucose, appetite, and energy. This is where GLPro has emerged as the #1 Natural Blood Sugar Formula Doctors And Insiders Are Talking About (Verified)....

Read more

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 24, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective October 20, 2025, the Company granted 600 restricted stock units (RSUs) to New Employee 1, 600 RSUs to New Employee 2, and 300 RSUs to New Employee 3.The RSUs for New Employees 1, 2 and 3 vest over one year starting from each employee's date of hire. The RSUs for New Employees 1, 2 and 3 were granted as an inducement material to each employee's...

Read more

StimCell Energetics Inc. Successfully Uplists to OTCQB Market

October 24, 2025 3:00 PM

StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is pleased to announce its successful uplisting to the OTCQB Venture Market, effective October 24, 2025. This significant milestone reflects the company's commitment to enhancing transparency, improving liquidity, and expanding its visibility within the investment community.The OTCQB,...

Read more

ASCP Introduces Age-Friendly Pharmacy (AFP) Recognition

October 24, 2025 1:00 PM

ASCP has introduced a new Age-Friendly Pharmacy (AFP) recognition, designed in partnership with the University of Maryland School of Pharmacy's Peter Lamy Center on Drug Therapy and Aging to provide pharmacies with acknowledgment, support, and educational services to assert their leadership in meeting the needs of older adults by providing age-friendly 4Ms care."We are pleased to introduce the AFP recognition and this new opportunity to...

Read more

Dental Materials and Implant Systems in Istanbul: What Patients Should Know (2025)

October 24, 2025 12:45 PM

Istanbul has rapidly become a global destination for dental implant in Turkey, attracting patients from the US, UK, Australia, and other countries. With a surge in medical tourism, patients increasingly want to know not only which clinics provide excellent care but also which implant brands and dental materials guarantee long-term results. Are Dental Materials in Istanbul Imported or Locally Made?Many patients wonder if dental implants and...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as Official Apple Developer

October 24, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), a technology-driven company specializing in innovative digital health and AI applications, today announced that it has been formally approved as an Apple Developer. This approval enables the company to create, test, and distribute mobile applications for iOS users worldwide. "Becoming an approved Apple Developer represents a key step in our mission to introduce accessible and intelligent...

Read more

Interactive Strength Inc. (NASDAQ: TRNR) to Release Third-Quarter Results on Friday, November 14, 2025

October 24, 2025 9:25 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR, FORME and Wattbike brands and pending acquirer of Sportstech, today announced it will release financial results for its third quarter ended September 30, 2025 as the market opens on Friday, November 14, 2025. Following the filing of its Form 10-Q, the Company as usual will publish a shareholder letter that discusses...

Read more

Real-Life Magic: Transforming Healing Into Prosperity

October 24, 2025 9:00 AM

What if healing wasn't just about survival-but thriving? At this year's Cannadelic Global Summit, Dr. Lauren Leiva returns to the main stage with her electrifying keynote: "Real-Life Magic: Transforming Healing Into Prosperity."A powerhouse of integrative science and embodied wisdom, Dr. Leiva invites us into the alchemical space where trauma becomes fuel, and wellness becomes wealth-not just financial, but spiritual, relational, and...

Read more

MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication

October 24, 2025 7:30 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced the initiation of the multiple ascending dose (MAD) portion of its ongoing Phase 1 clinical trial evaluating its lead oral candidate, Ketamir-2, in healthy volunteers. The Company also announced that it has selected...

Read more

Genflow Biosciences PLC Announces Holding(s) in Company

October 24, 2025 2:00 AM

TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of registered office (if applicable)rickmansworthCountry of registered office (if applicable)United Kingdom4. Details of the shareholderFull name of...

Read more

The Skin Science Company Reports Record Growth, Strengthening Its Position Among Australia's Trusted Skincare Manufacturers

October 23, 2025 11:20 PM

The Skin Science Company, an Australian skincare manufacturer based in Melbourne, has reported record growth following more than five years of consistent expansion within the cosmetic ingredients and skincare manufacturing sector. The company's continued success reflects its commitment to scientific formulation, product integrity, and sustainable production practices that support both domestic and international markets. Rooted in...

Read more